1. |
Liberman AL, Prabhakaran S. Cryptogenic stroke: how to define it? How to treat it?. Curr Cardiol Rep, 2013, 15(12): 423.
|
2. |
Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg, 2010, 110(2): 135-147.
|
3. |
Kim DW, Cho JS, Cho JY, et al. The association between aortic regurgitation and undetermined embolic infarction with aortic complex plaque. Int J Stroke, 2017, 13(4): 391-399.
|
4. |
Lippi G, Favaloro EJ, Franchini M. Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT. J Thromb Thrombolysis, 2012, 34(3): 360-366.
|
5. |
马冰, 陈欣, 刘奕婷, 等. 卵圆孔未闭与中老年人隐源性卒中关系的Meta分析. 中国循证心血管医学杂志, 2013, 5(5): 453-456.
|
6. |
Trabattoni D, Fabbiocchi F, Montorsi PA, et al. Sustained long-term benefit of patent foramen ova le closure on migraine. Catheter Cardiovasc Interv, 2011, 77(4): 570-574.
|
7. |
Sondergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med, 2017, 377(11): 1033-1042.
|
8. |
Bailey EL, Smith C, Sudlow CL, et al. Pathology of lacunar ischemic stroke in Humansu: a systematic review. Brain Pathol, 2012, 22(5): 583-591.
|
9. |
Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol, 2006, 47(2): 440-445.
|
10. |
Del Sette M, Rizzi D, Pretta S, et al. Magnitude of right-to-left shunt as the only determinant of stroke in a pair of identical twins. Neurol Sci, 2004, 25(3): 148-150.
|
11. |
Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke, 1998, 29(5): 944-948.
|
12. |
Staubach S, Steinberg DH, Zimmermann WA, et al. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv, 2009, 74(6): 889-895.
|
13. |
Liu JR, Plötz BM, Rohr A, et al. Association of right-to-left shunt with frontal white matter lesions in T2-weighted MR imaging of stroke patients. Neuroradiology, 2009, 51(5): 299-304.
|
14. |
Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology, 2011, 76(22): 1911-1917.
|
15. |
Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med, 2013, 368(12): 1092-1100.
|
16. |
Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med, 2017, 377(11): 1011-1021.
|
17. |
Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med, 2017, 377(11): 1022-1032.
|
18. |
Shah R, Nayyar M, Jovin IS, et al. Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke a systematic review and meta-analysis. Ann Intern Med, 2018, 168(5): 335-342.
|
19. |
De Rosa S, Sievert H, Sabatino JA, et al. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Ann Intern Med, 2018, 168(5): 343-350.
|
20. |
付强, 郭彩霞, 杜丽娟, 等. 经导管封堵术治疗不明原因卒中合并卵圆孔未闭患者的临床疗效及预后. 中华心血管病杂志, 2018, 46(11): 882-886.
|